BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 627735)

  • 1. Experimental osteomyelitis. V. Therapeutic trials with oxacillin and sisomicin alone and in combination.
    Norden CW
    J Infect Dis; 1978 Feb; 137(2):155-60. PubMed ID: 627735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental osteomyelitis. IV. Therapeutic trials with rifampin alone and in combination with gentamicin, sisomicin, and cephalothin.
    Norden CW
    J Infect Dis; 1975 Nov; 132(5):493-9. PubMed ID: 1185015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental chronic staphylococcal osteomyelitis in rabbits: treatment with rifampin alone and in combination with other antimicrobial agents.
    Norden CW
    Rev Infect Dis; 1983; 5 Suppl 3():S491-4. PubMed ID: 6635438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clindamycin treatment of experimental chronic osteomyelitis due to Staphylococcus aureus.
    Norden CW; Shinners E; Niederriter K
    J Infect Dis; 1986 May; 153(5):956-9. PubMed ID: 3701108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of antistaphylococcal activity of nafcillin and oxacillin by sisomicin and netilmicin.
    Watanakunakorn C; Glotzbecker C
    Antimicrob Agents Chemother; 1977 Sep; 12(3):346-8. PubMed ID: 907328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental osteomyelitis caused by Pseudomonas aeruginosa.
    Norden CW; Keleti E
    J Infect Dis; 1980 Jan; 141(1):71-5. PubMed ID: 6767790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of experimental chronic osteomyelitis due to staphylococcus aureus with vancomycin and rifampin.
    Norden CW; Shaffer M
    J Infect Dis; 1983 Feb; 147(2):352-7. PubMed ID: 6827150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of sisomicin and netilmicin alone and in combination with nafcillin, oxacillin and methicillin against enterococci.
    Watanakunakorn C; Glotzbecker C
    Chemotherapy; 1978; 24(4):236-9. PubMed ID: 648236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of experimental chronic osteomyelitis due to Staphylococcus aureus with ampicillin/sulbactam.
    Norden CW; Budinsky A
    J Infect Dis; 1990 Jan; 161(1):52-3. PubMed ID: 2295859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of experimental staphylococcal osteomyelitis with rifampin and trimethoprim, alone and in combination.
    Norden CW; Keleti E
    Antimicrob Agents Chemother; 1980 Apr; 17(4):591-4. PubMed ID: 7396451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of acute pelvic inflammatory diseases with a new antibiotic compound preparation (author's transl)].
    Burmucic R
    Wien Med Wochenschr; 1980 Nov; 130(22):744-9. PubMed ID: 7467388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model.
    Yin LY; Lazzarini L; Li F; Stevens CM; Calhoun JH
    J Antimicrob Chemother; 2005 Jun; 55(6):995-1002. PubMed ID: 15857944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacies of liposomal amikacin (MiKasome) plus oxacillin versus conventional amikacin plus oxacillin in experimental endocarditis induced by Staphylococcus aureus: microbiological and echocardiographic analyses.
    Xiong YQ; Kupferwasser LI; Zack PM; Bayer AS
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1737-42. PubMed ID: 10390232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between antibiotic concentration in bone and efficacy of treatment of staphylococcal osteomyelitis in rats: azithromycin compared with clindamycin and rifampin.
    O'Reilly T; Kunz S; Sande E; Zak O; Sande MA; Täuber MG
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2693-7. PubMed ID: 1336342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of experimental osteomyelitis by liposomal antibiotics.
    Kadry AA; Al-Suwayeh SA; Abd-Allah AR; Bayomi MA
    J Antimicrob Chemother; 2004 Dec; 54(6):1103-8. PubMed ID: 15486079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic synergism in enterococcal endocarditis.
    Carrizosa J; Kaye D
    J Lab Clin Med; 1976 Jul; 88(1):132-41. PubMed ID: 819602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of A-56619, A-56620, and nafcillin in the treatment of experimental Staphylococcus aureus osteomyelitis.
    Mader JT; Morrison LT; Adams KR
    Antimicrob Agents Chemother; 1987 Feb; 31(2):259-63. PubMed ID: 3566251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter: Adequacy of antibiotic dosages in treatment of osteomyelitis.
    Davis SD
    J Infect Dis; 1976 Feb; 133(2):239. PubMed ID: 1245770
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experience with sisomicin in pediatrics (author's transl)].
    Weingärtner L; Sitka U; Patsch R; Burchardt U; Richter I
    Infection; 1979; 7(3):119-27. PubMed ID: 383623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of daptomycin combined with rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus (MRSA) acute osteomyelitis.
    Lefebvre M; Jacqueline C; Amador G; Le Mabecque V; Miegeville A; Potel G; Caillon J; Asseray N
    Int J Antimicrob Agents; 2010 Dec; 36(6):542-4. PubMed ID: 20851576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.